Table 2 Total healthcare resource utilization in patients with NVAF treated with dabigatran or warfarin
From: Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Outcome | Dabigatran | Warfarin | P valueb |
|---|---|---|---|
N | 1110 | 1110 | |
Hospitalization | |||
Number of patients hospitalized, n (%) | 284 (25.6) | 332 (29.9) | |
All cause hospitalizations, n | 381 | 475 | |
Mean PPPYa [SD] (95% CI) | 0.92 [3.10] (0.74, 1.11) | 1.13 [2.90] (0.96, 1.30) | 0.0124 |
Median PPPYa (25p, 75p) | 0.0 (0.0, 1.0) | 0.0 (0.0, 1.0) | |
ER visits | |||
Number of patients with an ER visit, n (%) | 309 (27.8) | 378 (34.1) | |
All cause ER visits, n | 563 | 780 | |
Mean PPPYa [SD] (95% CI) | 1.32 [4.04] (1.08, 1.56) | 1.56 [3.74] (1.34, 1.78) | 0.0011 |
Median PPPYa (25p, 75p) | 0.0 (0.0, 1.0) | 0.0 (0.0, 1.6) | |
Physician office visits | |||
Number of patients with a physician office visit, n (%) | 1068 (96.2) | 1084 (97.7) | |
All cause physician office visits (n) | 11,571 | 18,765 | |
Mean PPPYa [SD] (95% CI) | 21.43 [17.98] (20.37, 22.49) | 29.41 [18.68] (28.31, 30.51) | < 0.0001 |
Median PPPYa (25p, 75p) | 17.0 (10.2, 27.3) | 26.4 (16.5, 39.0) | |
Outpatient visits | |||
Number of patients with an outpatient visit, n (%) | 945 (85.1) | 1040 (93.7) | |
All cause outpatient visits (n) | 5563 | 13,029 | |
Mean PPPYa [SD] (95% CI) | 10.86 [15.44] (9.95, 11.77) | 22.02 [23.37] (20.64, 23.39) | < 0.0001 |
Median PPPYa (25p, 75p) | 6.6 (3.0, 12.4) | 16.6 (6.7, 29.0) | |